A guideline for predeposit autologous transfusion was published in 2007.1 Practices have changed in the intervening years, and in line with British Society for Haematology (BSH) guidelines processes, this guideline required review and revision. The increasing safety of allogeneic transfusion has reduced the need for autologous collection. In addition, disadvantages have been noted, which are discussed below.
Declaration of Interests
The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.